A CAGR of 13.8% is predicted for the Energy-based Aesthetic Devices Market, which is now valued at USD 5.8 billion. By 2032, it is anticipated that the market for energy-based cosmetic devices would be worth USD 21.14 billion.
An increase in the incidence of skin conditions like dryness, acne, and fungal skin infections is the main factor driving the market for energy-based aesthetic devices. Additionally, the industry is growing because to technological developments in aesthetic gadgets.
For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8038
The market for energy-based cosmetic devices faced tough hurdles as a result of the COVID-19 outbreak. Lockdowns caused the closure of med spas, dermatological clinics, beauty salons, and retail stores in various nations because the bulk of aesthetic treatments were not medically essential.
Key findings of the Energy-based Aesthetic Devices market study:
- Regional breakdown of the Energy-based Aesthetic Devices market based on predefined taxonomy.
- Innovative manufacturing processes implemented by Energy-based Aesthetic Devices vendors in detail.
- Region-wise and country-wise fragmentation of the Energy-based Aesthetic Devices market to grasp the revenue, and growth outlook in these areas.
- Changing preferences among consumers across various regions and countries.
- Factors (Positive and Negative) impacting the growth of the global Energy-based Aesthetic Devices market.
Competitive Landscape
March 2022, Alma Lasers Ltd., Ownership
- Alma Lasers Ltd., a wholly-owned subsidiary of Sisram Medical Ltd., launched two products in the United States market in March 2022: the Alma TED1, which addresses consumer demand for hair growth treatments, and the cannabidiol CBD+ professional skincare solution, which is used to visibly reduce redness and calm the appearance of stressed skin.
May 2022, Sisram Medical Ltd., Expansion
- Sisram Medical Ltd. is anticipated to expand its home-use brand, LMNT, in China in May 2022. It is the first step toward providing consumers with a beauty treatment they can use at home to supplement their wellness routine. The goal is to create useful content and maintain long-term engagement with its target audiences.
February 2021, US FDA, Drug Approval
- Restylane Defyne was approved by the US FDA in February 2021 for the treatment and correction of mild-to-moderate chin restoration in adults over the age of 21.
2020, InMode Ltd., Certification
- InMode Ltd. announced the certification of Evolve Tone by Health Canada in 2020. The Evolve Tone is a hands-free aesthetic device that incorporates three body remodelling technologies: Trim, Tite, and Tone.
Key Companies Profiled:
- Syneron Medical Ltd.
- Merz Pharma GmbH & Co.
- KGaA
- Lumenis Ltd.
- Alma Lasers Inc.
- Zeltiq
- El.En.
- Cutera
- Sisram
- Allergan Plc
- Cynosure
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8038
Key Segments
- By Application :
- Body Contouring & Skin Tightening
- Skin Rejuvenation
- Wrinkles
- Acne & Other Scars
- Skin Pigmentation
- Aging
- Hair Removal
- Leg Vein Treatment
- Vaginal Rejuvenation
- Pigmented Lesion & Tattoo Removal
- Others
- By End-use :
- Hospital/Surgery Center
- Medspa
- Traditional Spa
- HCP Owned Clinic
- By Region :
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
